BDX and WAT Related Headlines
Go Back- BD completes spin-off and merger of biosciences unit with Waters Corp
- BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
- Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
- Waters shareholders approve BD biosciences unit combination
- BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
- Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
- KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
- Morgan Stanley Starts Waters Corp. (WAT) at Equalweight, 'High Quality Core Business but BDX Deal Bears Monitoring'
- RBC starts Becton Dickinson at Sector Perform, sees limited upside until 2027
- Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures
- Waters to merge with BD's biosciences unit in $17.5 billion deal
- Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
BDX and WAT Related Press Releases
Go Back- BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
- Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
- BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
- Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
- Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
